Abstract
Type 2 diabetes is an inevitably progressive disease, with irreversible β cell failure. Glycogen synthase kinase and Glukokinase, two important enzymes with diverse biological actions in carbohydrate metabolism, are promising targets for developing novel antidiabetic drugs. A combinatorial structure-based molecular docking and pharmacophore modelling study was performed with the compounds of Hippophae salicifolia and H. rhamnoides as inhibitors. Docking with Discovery Studio 3.5 revealed that two compounds from H. salicifolia, viz Lutein D and an analogue of Zeaxanthin, and two compounds from H. rhamnoides, viz Isorhamnetin-3-rhamnoside and Isorhamnetin-7-glucoside, bind significantly to the GSK-3 β receptor and play a role in its inhibition; whereas in the case of Glucokinase, only one compound from both the plants, i.e. vitamin C, had good binding characteristics capable of activation. The results help to understand the type of interactions that occur between the ligands and the receptors. Toxicity predictions revealed that none of the compounds had hepatotoxic effects and had good absorption as well as solubility characteristics. The compounds did not possess plasma protein-binding, crossing blood–brain barrier ability. Further, in vivo and in vitro studies need to be performed to prove that these compounds can be used effectively as antidiabetic drugs.








Similar content being viewed by others
References
Accelrys Software Inc. 2012 Discovery Studio Modeling Environment, Release 3.5 (San Diego)
American Diabetes Association 2011 Standards of medical care in diabetes. Diab. Care 34 S11–S61
Basistha BC, Sharma NP, Lepcha L, Arrawatia A and Sen A 2010 Ecology of Hippophae salicifolia D. Don of temperate and subalpine forests of North Sikkim Himalayas – a case study. Symbiosis 50 87–95
Berman HM 2008 The Protein Data Bank: A Historical perspective. Acta Cryst. Sect. A A64 88–95
Brooks BR, Brooks CL, Mackerell AD, Nilsson L, Petrella RJ, Roux B, et al. 2009 CHARMM: The Bio-molecular simulation Program. J. Comput. Chem. 30 1545–1615
Cheng A and Merz Jr KR 2003 Prediction of aqueous solubility of a diverse set of compounds using quantitative structure-property relationships. J. Med. Chem. 46 3572–3580
Christaki E 2012 Hippophae Rhamnoides L. (Sea Buckthorn): a potential source of nutraceuticals. Food Public Health 2 69–72
Desbois-Mouthon C, Cadoret A, Blivet-Van Eggelpoël MJ, Bertrand F, Cherqui G, Perret C and Capeau J 2001 Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation. Oncogene 20 252–259
Efanov AM, Barrett DG, Brenner MB, Briggs SL, Delaunois A, Durbin JD, Giese U, Guo H, et al. 2005 A novel Glucokinase activator modulates pancreatic islet and hepatocyte function. Endocrinology 146 3696–3701
Ekins S and Swaan PW 2004 Development of computational models for enzymes, transporters, channels and receptors relevant to ADME/TOX. Rev. Comput. Chem. 20 333–415
Giugliano D, Ceriello A and Paolisso G 1995 Diabetes mellitus, hypertension and cardiovascular disease : which role for oxidative stress? Metabolism 44 363–368
Goyal AK, Basistha BC, Sen A and Middha SK 2011 Antioxidant profiling of Hippophae salicifolia growing in sacred forests of Sikkim, India. Funct. Plant Biol. 38 697–701
Heinäaho M, Hagerman AE, Julkunen-Tiitto R, Hagerman AE and Julkunen-Tiitto R 2009 effect of different organic farming methods on the phenolic composition of Sea Buckthorn berries. J. Agri. Food Chem. 57 1940–1947
Hodgson J 2001 ADMET – turning chemicals into drugs. Nat. Biotech. 19 722–726
Johnson D, Shepherd RM, Gill D, Gorman T, Smith DM and Dunne MJ 2007 Glucose- dependent modulation of insulin secretion and intracellular calcium ions by GKA50, a glucokinase activator. Diabetes 56 1694–1702
Khanna V and Ranganathan S 2009 Physicochemical property space distribution among human metabolites, drugs and toxins. BMC Bioinformatics 10 S10
Korstanje C, Krauwinkel W and Doesum-Wolters FLC 2011 Tamsulosin shows a higher unbound drug fraction in human prostate than in plasma: a basis for uroselectivity? Br. J. Clin. Pharmacol. 72 218–225
Laakso M and Lehto S 1997 Epidemiology of macro-vascular disease in diabetes. Diab. Rev. 5 294–315
Larrey D 2002 Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin. Liver Dis. 22 145–155
Li TS and Schroeder WR 1996 Sea Buckthorn (Hippophae rhamnoides L.): a multipurpose plant. HortTechnology 6 370–380
Lipinski CA, Lombardo F, Dominy BW and Feeney PJ 2001 Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Rev. 46 3–26
Long S-H, Yu Z-Q, Shuai L, Guo Y-L, Duan D-L, Xu X-Y and Li X-D 2012 The hypoglycemic effect of the kelp on diabetes mellitus model induced by alloxan in rats. Int. J. Mol. Sci. 13 3354–3365
Marvin was used for drawing, displaying and characterizing chemical structures, substructures and reactions, Marvin 5.4.0, 2010, ChemAxon (http://www.chemaxon.com)
Middha SK, Bhattacharjee B, Saini D, Baliga MS, Nagaveni MB and Usha T 2011 Protective role of Trigonalla foenum in diabetic rats. Eur. Rev. Med. Pharmacol. Sci. 15 427–435
Miller SP, Anand GR, Karschnia EJ, Bell GI, LaPorte DC and Lange AL 1999 Characterization of Glucokinase mutations associated with maturity-onset diabetes of the young type 2 (MODY- 2): different Glucokinase defects lead to a common phenotype. Diabetes 48 1645–1651
Nordlie RC, Foster JD and Lange AJ 1999 Regulation of glucose production by the liver. Annu. Rev. Nutr. 19 379–406
Olokoba AB, Obateru OA and Olokoba LB 2012 Type 2 diabetes mellitus: A review of current trends. Oman Med. J. 27 269–273
Patil R, Das S, Stanley A, Yadav L, Sudhakar A and Varma AK 2010 Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing. PLoS One 5 e12029
Rousi A 1971 The genus Hippophae L: A taxonomic study. Ann. Bot. Fennici 8 177–227
Sharma M and Naik PK 2013 To study the mode and mechanism of interaction of Angiopoietin II with receptor tyrosine kinase Tie-2 using molecular mechanics and molecular dynamics approach. Int. J. Fund. Appl. Sci. 2 8–11
Singh V 1998 Sea-buckthorn a wonder plant of dry temperate Himalayas. Ind. J. Horticulture 43 6–8
Suri C and Naik PK 2012 Elucidating the precise interaction of reduced and oxidized states of Neuroglobin with Ubc12 and Cop9 using molecular mechanics studies. Int. J. Fund. Appl. Sci. 1 74–77
Usha T, Tripathi P, Pande V and Middha SK 2013 Molecular docking and quantum mechanical studies on Pelargonidin-3-Glucoside as renoprotective ACE inhibitor. ISRN Comp. Biol. doi:10.1155/2013/428378
Van-Aalten DM, Bywater R, Findlay JB, Hendlich M, Hooft RW and Vriend G 1996 PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules. J. Comput. Aided Mol. Des. 10 255–262
Wild S, Roglic G, Green A, Sicree R and King H 2004 Global Prevalence of Diabetes- Estimates for the year 2000 and projections for 2030. Diabetes Care 27 1047–1053
Yamashita H, Takenoshita M, Sakurai M, Bruick RK, Henzel WJ, Shillinglaw W, Arnot D and Uyeda K 2001 A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc. Natl. Acad. Sci. 98 9116–9121
Acknowledgements
The authors wish to thank the Deanship of Life Science Research, DBT-Bioinformatics Infrastructure Facility, and BT-Finishing School, at Maharani Lakshmi Ammanni College for Women, for providing infrastructure and the licensed software to carry out the project.
Author information
Authors and Affiliations
Corresponding author
Additional information
[Middha SK, Goyal AK, Faizan SA, Sanghamitra N, Basistha BC and Usha T 2013 In silico–based combinatorial pharmacophore modelling and docking studies of GSK-3β and GK inhibitors of Hippophae. J. Biosci. 38 1–10] DOI 10.1007/s12038-013-9367-y
Rights and permissions
About this article
Cite this article
Middha, S.K., Goyal, A.K., Faizan, S.A. et al. In silico–based combinatorial pharmacophore modelling and docking studies of GSK-3β and GK inhibitors of Hippophae . J Biosci 38, 805–814 (2013). https://doi.org/10.1007/s12038-013-9367-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12038-013-9367-y


